AbbVie Archives - Page 2 of 4 - Express Pharma

AbbVie and Eli Lilly exit UK drug pricing agreement

Abbvie raises sales outlook of two new drugs to more than $17.5 billion in 2025

AbbVie and Cugene announce collaboration in autoimmune diseases

Dragonfly and AbbVie expand collaboration in oncology and autoimmune disease

US FDA extends review period for expanded use of Abbvie’s psoriasis drug

US FDA approves second indication for Skyrizi to treat adults with active psoriatic arthritis

US FDA approves drugs from AbbVie and Pfizer to treat eczema

AbbVie submits applications for Upadacitinib in to US FDA and EMA

US FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly

FDA grants BTD for Venclexta in combination with azacitidine to treat patients with myelodysplastic syndromes